Home  >  Products  >  EFTUD1 (elongation factor Tu GTP binding domain containing 1 ) Blocking Peptide (the C terminal of EFTUD1)(100ug)
EFTUD1 (elongation factor Tu GTP binding domain containing 1 ) Blocking Peptide (the C terminal of EFTUD1)(100ug)

EFTUD1 (elongation factor Tu GTP binding domain containing 1 ) Blocking Peptide (the C terminal of EFTUD1)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EFTUD1 Antibody (ARP68287_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP68287
Size: 100ug
Weight: 117kDa
Gene: 79631
Format: Lyophilized powder
Target: EFTUD1 is involved in the biogenesis of the 60S ribosomal subunit and translational activation of ribosomes. Together with SBDS, EFTUD1 triggers the GTP-dependent release of EIF6 from 60S pre-ribosomes in the cytoplasm, thereby activating ribosomes for translation competence by allowing 80S ribosome assembly and facilitating EIF6 recycling to the nucleus, where it is required for 60S rRNA processing and nuclear export. EFTUD1 has low intrinsic GTPase activity. GTPase activity is increased by contact with 60S ribosome subunits.
Alternative names: FAM42A; HsT19294; RIA1